静脉注射低剂量咪唑安定减少依托咪酯引起的肌阵颤:一项关于对行心脏复律治疗的患者的前瞻性,随机性研究
研究背景:在未用术前药的病人,用依托咪酯进行全麻诱导而发生肌阵颤现象是一个普遍的问题。
方法:在一个双盲研究中,40例行心脏复律治疗的患者(ASA分级III–IV级)随机分组,分别在静注0.3mg/kg的依托咪酯前90秒接受0.015mg/kg的咪唑安定或安慰剂注射。肌阵颤和镇静水平都在0至3分之间进行打分,脉搏氧饱和度,非有创性血压监测和心率都被记录。
结果:在静注依托咪酯后,咪唑安定组有两例患者(10%)发生了肌阵颤现象,而对照组有20例患者(50%)发生了肌阵颤(P = 0.006)。两组间相比,没有显著性差异,尤其在注射依托咪酯后恢复的五分钟内两组间无差异。
结论:在使用依托咪酯之前90秒静脉注射0.015mg/kg的咪唑安定能有效地减少肌阵颤的发生,而且在短小手术后会不延长未使用术前用药患者的恢复时间。
(论文出处:Anesth Analg 2007;105:1298 –302)
华译网 上海翻译公司曾经翻译过大量有关静脉注射低剂量咪唑安定减少依托咪酯引起的肌阵颤资料文件。
Low-Dose Intravenous Midazolam Reduces Etomidate-Induced Myoclonus: A Prospective, Randomized Study in Patients Undergoing Elective Cardioversion
研究背景: Myoclonic movements are a common problem in unpremedicated patients during induction of anesthesia with etomidate.
方法: In a double-blind fashion, 40 patients (ASA physical status III–IV) scheduled for elective cardioversion were randomly assigned to receive either 0.015 mg/kg midazolam or placebo 90 s before the injection of 0.3 mg/kg etomidate. Myoclonic movements and sedation were recorded on a scale between 0 and 3. Pulse oximetry, noninvasive arterial blood pressure, and heart rate were recorded during the study period.
结果: Two patients (10%) in the midazolam group had myoclonic movements after the administration of etomidate, whereas 10 of the 20 patients (50%) receiving placebo experienced such movements (P = 0.006). No other differences were found between the groups; in particular, there was no difference in recovery 5 min after the administration of etomidate.
结论: IV midazolam 0.015 mg/kg administered 90 s before induction of anesthesia with etomidate is effective in reducing myoclonic movements and does not prolong recovery in unpremedicated patients after short procedures. (Anesth Analg 2007;105:1298 –302)
|